"We Envision Growth Strategies Most Suited
to Your Business"
The global spirometer market size is expected to experience a considerable growth by reaching USD 716.8 million by 2027. This is attributable to the increasing prevalence of chronic obstructive pulmonary disease (COPD) that is propelling the demand for advanced spirometer across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Spirometer Market Size, Share & COVID-19 Impact Analysis, By Product Type (Devices, Software, Accessories & Consumables), By Type (Volume Measurement and Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Others), By End User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, and Other Facilities), and Regional Forecast, 2020-2027.” The report further mentions that the market generated a revenue of USD 504.2 million in 2019 and is likely to exhibit a CAGR of 4.7% between 2020 and 2027.
AireHealth Inc. Merges with BreathResearch to Expand its Product Portfolio
In June 2020, AireHealth Inc, a digital health solutions provider, announced its merger with BreathResearch, a leading respiratory healthcare company. The move is expected to revolutionize care for over 100 million patients that suffer from chronic respiratory diseases globally. In addition to this, the combined companies will operate as AireHealth, while addressing the rising challenges owing to the respiratory illness that results in cost incurred over USD 130 billion annually and causes 49.2 deaths per 100,000 people across the globe.
Stacie Ruth, CEO of AireHealth, says, “We have planned to accelerate our journey into respiratory digital therapeutics by announcing the acquisition of a company that aids in saving lungs and lives, and we perceive BreathResearch as that company.” Such initiatives are expected to contribute to the growth of the global market in the forthcoming years.
To get a detailed report summary and research scope of this market, click here:
Increasing Prevalence of Chronic Obstructive Pulmonary Disease to Surge Demand
Chronic obstructive pulmonary disease (COPD) is a type of chronic inflammatory lung disease that obstructs airflow from the lungs. According to the National Heart, Lung, and Blood Institute, COPD is the leading cause of deaths owing to respiratory illness that affects around 16 million Americans every year. The increasing prevalence of COPD is driving the demand for advanced spirometer devices across the globe. The growing investment by the government to develop effective devices to manage and diagnose respiratory illness is further anticipated to contribute to the global spirometry market growth during the forecast period.
Merger and Acquisitions by Major Companies to Strengthen Their Market Positions
The global spirometer market is consolidated by the presence of major companies such as COSMED srl and ndd Medizintechnik AG. These established companies are acquiring other companies with an aim to expand their spirometer devices portfolio and strengthen their positions in the highly competitive global marketplace. The other key players such as Morgan Scientific, SCHILLER, and MGC Diagnostic, among others are adopting strategies such as collaboration and partnership to maintain their presence that is further anticipated to bode well for the growth of the market in the forthcoming years.
List of the Companies Profiled in the Global Market:
Further Report Findings:
Table of Segmentation:
Value (USD Million)
Product Type; Type; Application; End User; and Geography
By Product Type
By End User